酒精及其他物质使用障碍对进食障碍患者死亡率的影响:一项全国性登记库回顾性队列研究
该研究基于丹麦全国登记库,纳入20759例进食障碍患者与83036名匹配对照,评估酒精及其他物质使用障碍与全因死亡率的关联。结果显示,合并物质使用障碍的进食障碍患者全因死亡风险显著高于无物质使用障碍的对照,且酒精和/或大麻使用障碍与硬性药物使用障碍呈现叠加效应。作者认为预防和治疗该患者群体的物质使用障碍对降低死亡率至关重要。
要点
- 合并酒精和/或大麻使用障碍的神经性厌食、神经性贪食和未特定进食障碍患者,全因死亡风险分别是对照的11.28、5.86和10.86倍。
- 合并硬性药物使用障碍(单独或联合酒精和/或大麻)的上述三类患者,全因死亡风险分别是对照的22.34、11.43和15.53倍。
- 物质使用障碍对进食障碍患者超额死亡率具有叠加效应,作者认为预防和治疗该群体物质使用障碍对降低死亡率至关重要。
核心结论
- 物质使用障碍对进食障碍患者的超额死亡率具有叠加效应,作者认为预防和治疗该患者群体的物质使用障碍对降低死亡率至关重要。
研究设计与样本
- 基于丹麦全国登记库的回顾性队列研究,纳入20759例进食障碍患者和83036名匹配对照。
主要发现
- 合并酒精和/或大麻使用障碍的神经性厌食患者全因死亡风险调整后风险比为11.28(95%CI=7.01, 18.16),神经性贪食患者为5.86(95%CI=3.37, 10.1),未特定进食障碍患者为10.86(95%CI=6.74, 17.50),均高于无物质使用障碍的对照。
- 合并硬性药物使用障碍(单独或联合酒精和/或大麻)的神经性厌食患者调整后风险比为22.34(95%CI=15.13, 33.00),神经性贪食患者为11.43(95%CI=7.14, 18.28),未特定进食障碍患者为15.53(95%CI=10.15, 23.78),均高于无物质使用障碍的对照。
- 无物质使用障碍的神经性厌食、神经性贪食和未特定进食障碍患者,调整后风险比分别为3.21(95%CI=2.43, 4.23)、1.24(95%CI=0.88, 1.77)和4.75(95%CI=3.57, 6.31);其中神经性贪食的95%CI跨1,未达统计学显著。
- 合并物质使用障碍的对照人群全因死亡风险也高于无物质使用障碍的对照,但程度远低于合并物质使用障碍的进食障碍患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Research is lacking on the contribution of different types of substance use disorders (SUDs) to excess mortality across the full spectrum of eating disorders. The authors assessed the association of alcohol use disorders and other SUDs with mortality in anorexia nervosa, bulimia nervosa, and unspecified eating disorder compared with matched control subjects. METHODS: A retrospective cohort study was conducted using Danish nationwide registers. The study included 20,759 patients with eating disorders and 83,036 matched control subjects. Hazard ratios were calculated to compare all-cause mortality risk between eating disorder patients and control subjects both with and without a lifetime SUD diagnosis (abuse or dependence of alcohol, cannabis, or hard drugs). RESULTS: For patients with each type of eating disorder, a higher risk of all-cause mortality was observed relative to control subjects without SUDs among those who abused alcohol and/or cannabis (adjusted hazard ratios for the anorexia nervosa, bulimia nervosa, and unspecified eating disorder patients, respectively, were 11.28 [95% CI=7.01, 18.16], 5.86 [95% CI=3.37, 10.1], and 10.86 [95% CI=6.74, 17.50]), or hard drugs alone or in combination with alcohol and/or cannabis (adjusted hazard ratios, respectively, were 22.34 [95% CI=15.13, 33.00], 11.43 [95% CI=7.14, 18.28], and 15.53 [95% CI=10.15, 23.78]), than in those without SUDs (adjusted hazard ratios, respectively, were 3.21 [95% CI=2.43, 4.23], 1.24 [95% CI=0.88, 1.77], and 4.75 [95% CI=3.57, 6.31]). Control subjects with SUDs also exhibited an elevated risk of all-cause mortality relative to control subjects without SUDs, although to a much lesser extent than eating disorder patients with SUDs. CONCLUSIONS: SUDs have an additive effect on excess mortality in patients with eating disorders. The prevention and treatment of SUDs in this patient group is thus imperative to reduce mortality.
引用
- Mellentin AI, Mejldal A, Guala MM, et al. The Impact of Alcohol and Other Substance Use Disorders on Mortality in Patients With Eating Disorders: A Nationwide Register-Based Retrospective Cohort Study. Am J Psychiatry. 2022. PMID: 34974750. doi:10.1176/appi.ajp.2021.21030274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。